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Objective: Growth differentiation factor 5 (GDF5) is important for joint formation and associated with
osteoarthritis (OA). Its role for the homeostasis of cartilage extracellular matrix (ECM) is, however, un-
known. The canonical Wnt signaling pathway is also implemented in OA and activation of the pathway
has detrimental effects on the cartilage ECM. The objective of this study was to investigate the effect of
GDF5 stimulation on the Wnt signaling pathway and on the expression of known modulators of cartilage
ECM.
Design: Human chondrocytes were cultured in the pellet mass system and stimulated with increasing
concentrations of GDF5. Expression of matrix modulating enzymes and canonical Wnt inhibitors dick-
kopf 1 (DKK1) and frizzled related protein (FRZB) were measured with quantitative PCR (qPCR). Protein
levels of matrix metalloprotease 13 (MMP13), DKK1 and b-catenin were measured with enzyme-linked
immunosorbent assay (ELISA). Canonical Wnt signaling was stimulated with Wnt3a and small molecule
CHIR-99021 and DKK1 was blocked with small molecule WAY-262611.
Results: In this study, we show that GDF5 stimulation of human chondrocytes inhibits expression of the
cartilage ECM degrading enzymes MMP13 and ADAMTS4 and stimulates the expression of cartilage
anabolic genes ACAN and SOX9. We further show that the stimulation inhibits the canonical Wnt
signaling pathway through expression of the canonical Wnt inhibitors DKK1 and FRZB. Finally we show
that inhibition of MMP13 expression through GDF5 stimulation is mediated by DKK1.
Conclusion: Herein, we provide evidence of a previously unknown link between GDF5 signaling and
canonical Wnt signaling that may contribute to the understanding of the molecular mechanisms of OA.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a progressive multifactorial disease where
age, obesity and inheritance are predisposing factors, however the
underlying molecular mechanisms are largely unknown1,2.
The progression of the disease is a result of mechanical wear and
an imbalance between anabolic and catabolic factors, including
dysregulation of the main cartilage extracellular matrix (ECM)
degrading enzymes matrix metalloprotease 13 (MMP13) and
aggrecanases (ADAMTS4 and 5)3,4. A critical regulatory system forL. Enochson, Department of
ahlgrenska Academy at the
1345 Gothenburg, Sweden.
hson), johan.stenberg@gu.se
Brittberg), anders.lindahl@
ternational. Published by Elsevier Lcartilage maintenance is the b-catenin mediated canonical Wnt
signaling pathway. This pathway is important during cartilage
development and its activation in the adult cartilage tissue leads to
hypertrophy, initiation of calciﬁcation and tissue degradation via
increased expression of ECM degrading components5e8. Wnt li-
gands show increased expressions after cartilage damage and in
tissues affected by OA, resulting in the subsequent activation of the
Wnt pathways in the cells9e11.
The canonical Wnt signaling pathway ligands, such as Wnt3a,
signal through the interactionwith two types of receptors at the cell
surface, the serpentine seven transmembrane Frizzled (FZD) family
receptors and the single-pass transmembrane low density lipo-
protein receptor related proteins 5 and 6 (LRP5/6). In the absence of
Wnt ligands, glycogen synthase kinase 3b (GSK3b) phosphorylates
the canonical Wnt signal mediator b-catenin, in a destruction
complex with axin, casein kinase 1-a and adenomatous polyposis
coli2. This phosphorylation leads to the ubiquitin-mediated degra-
dation of b-catenin in the proteasomes. Activation of the canonicaltd. All rights reserved.
Table I
The factorial design for the stimulation of pellets with GDF5 () 2 ng/ml, (c) 20 ng/
ml, (þ) 200 ng/ml and WAY-262601 () 0.01 mM, (c) 0.1 mM, (þ) 1 mM
Nr GDF5 WAY-262611
1 e e
2 þ e
3 e þ
4 þ þ
5 e c
6 þ c
7 c e
8 c þ
9 c c
10 c c
11 c c
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receptors, forming a functional ligandereceptor complex. This will
reduce the activity of GSK3b, resulting in an accumulation of newly
synthesized b-catenin in the cell cytosol, which leads to the sub-
sequent translocation of the protein into the cell nucleus5,12,13.
Nuclear b-catenin interacts with DNA bound T-cell factor/lymphoid
enhancer factor (TCF/LEF) proteins and thereby induces expression
of Wnt target genes such as peroxisome proliferator-activated
receptor delta (PPARD) and FOS-like antigen 1 (FOSL1)5,13,14.
Important regulators of the canonical Wnt signaling pathway are
the secreted Wnt antagonists frizzled related protein (FRZB) and
dickkopf 1 (DKK1)13. FRZB binds to extracellular Wnt ligands, pre-
venting them from interacting with the FZD receptors. DKK1 func-
tions as an inhibitory ligand to the LRP5/6 receptor, thereby
preventing the binding of the Wnt ligands to the receptor13. Single
nucleotide polymorphisms (SNPs) in the FRZB gene have shown as-
sociation with increased OA susceptibility15,16, and dysregulation of
theDKK1expression isassociatedwith increasedOAprogression17e21.
Growth and differentiation factor 5 (GDF5) belongs to the bone
morphogenetic protein (BMP) family and the transforming growth
factor ß (TGFß) superfamily. Also known as BMP14 and cartilage
derivedmatrix protein 1 (CDMP1), it was originally characterized as
a protein from cartilage extracts that could induce cartilage and
bone formation in subcutaneous implants22e25. It is a key regulator
of mesenchyme condensation and chondrogenic differentiation in
developing joints and mutations in the gene can lead to defects in
the developing skeleton22. Mutations in the GDF5 gene have also
been shown to cause increased susceptibility to develop OA. A
single nucleotide polymorphism (SNP, rs143383 T/C) located in the
50-UTR of the GDF5 gene has been shown to have a connection to
hip and knee OA in a range of ethnic groups. The result of this
mutation is a slight reduction in the activity of the GDF5 promoter,
indicating that even a minor imbalance in the GDF5 expression can
lead to OA26,27. What role GDF5 plays in the etiology of OA and how
GDF5 affects other signaling pathways in human cartilage is how-
ever still unknown.
The aim of this paper was to investigate the effect of GDF5
signaling on the expression of human cartilage ECM modulating
proteins. Furthermore we wanted to examine if GDF5 signaling
affected the expression of Wnt inhibitors in human chondrocytes,
and if that in turn had an impact on canonical Wnt signaling.
Methods
Cell expansion
Surplus human chondrocytes from ﬁve patients (average age 31)
undertaking ACI were cultured in chondrocyte expansion medium
consisting of Dulbecco’s Modiﬁed Eagle Medium/F12 (DMEM/F12,
Invitrogen, Paisley, UK) supplementedwith0.1mg/mL L-ascorbic acid
(Apotekets produktionsenhet, Umeå, Sweden), 1 PenicillineStrep-
tomycin (PAA Laboratories, Pasching, Austria), 2 mM L-glutamine
(Invitrogen) and10%humanserum, at37C in7%CO2and90%relative
humidity. Medium was changed two to three times per week. Sub-
culture was made with trypsin-EDTA solution (0.125% trypsin (Invi-
trogen) diluted in0.1MPBSwith0.2 g/L EDTA) at 80% cell conﬂuence.
During expansion the cells undergo dedifferentiation, which is
partially reverted during the following high-density pellet culture.
The cells are in this studydenotedaschondrocytes, fromtheiroriginal
phenotype, independent of degree of differentiation.
Reference biopsy material
Cartilage biopsy reference material from ﬁve OA patients (Ahl-
bäck score> 2, Mankin score> 4.5) and six control donors (Mankinscore < 1) was earlier characterized by Thorfve et al.10 and mRNA
was kindly provided for this study. Genes analyzed in the present
study have not been studied in this material previously. The anal-
ysis performed in the present study is in accordance with the
ethical approval of Thorfve et al. The expression levels of the
analyzed genes were compared to unstimulated and 200 ng/ml
GDF5 stimulated chondrocyte pellet cultures (n ¼ 3).
High-density pellet culture
Chondrocytes (passage 3) were resuspended at 1.25  106 cells/
ml in basic differentiation media (BDM) consisting of DMEM high
glucose (PAA Laboratories) supplemented with 100 nM dexa-
methasone (Sigma, St Louis, MO, USA), 1 insulin-transferrin-
selenous acid premix (ITS) (Invitrogen), 1.0 mg/ml human serum
albumin (HSA, Equitech-Bio, Kerrville, TX, USA) supplemented with
5.0 mg/ml linoleic acid (Sigma), 14 mg/ml L-ascorbic acid 2-
phosphate (Sigma) and 1 PenicillineStreptomycin. The cell sus-
pension was divided into aliquots of 200 ml to each well of an un-
coated ﬂat bottom 96-well plate (Costar, Corning, NY, USA). The
plate was centrifuged at 1,500 rpm for 5 min and incubated for 48 h
at 37C in 5% CO2 and 90% relative humidity to allow for pellet
formation. After 48 h the culture medium was changed to BDM
supplemented with appropriate growth factors (GFs); 2, 10, 100 or
200 ng/ml recombinant GDF5 (Nordic biosite, Stockholm, Sweden)
(dosage determined by in house pilot studies and previous pub-
lished studies28,29), 50 ng/ml recombinant Wnt3a7 (R&D systems,
Minneapolis, MN, USA), 0.5 mM GSK3b inhibitor CHIR-99021 (Axon
Medchem, Groningen, the Netherlands), 0.01, 0.1 or 1 mM DKK1
inhibitor WAY-262611 (Millipore, Billerica, MA, USA). Medium was
changed three times per week for 21 days, whereafter the pellets
were snap-frozen in liquid nitrogen and stored at 80C.
Response surface modeling
Factorial design of experiments (DoE) was used for investigating
co-stimulation of chondrocytes with GDF5 and WAY-262611 to
address how these factors simultaneously affect the cells. In short,
the DoE method allows for a systematic approach to optimization
processes and for studying synergistic effects. It is based on
deﬁning mathematical relationships between input factors and
output response. The results are often displayed in response sur-
faces showing which levels of input factors that result in the
highest or lowest effect on the output variable. For a comprehensive
review, please read Mandenius et al.30. The DoE setup for GDF5 and
WAY-262611 interactions was designed with computer software
Modde 8.0 (Umetrics, Umea, Sweden). This resulted in 11 different
medium mixtures with combinations of low (), mid (c), or high
(þ) concentration of the additives. For concentration combinations
L. Enochson et al. / Osteoarthritis and Cartilage 22 (2014) 566e577568see Table I. The 11 medium formulations were used to stimulate
two chondrocyte pellets each. Pellets were cultured for 21 days in
respective medium with media changes three times per week,
whereafter the pellets were snap-frozen in liquid nitrogen and
stored at 80C.
Isolation of total RNA
Frozen pellet cultures were homogenized in 1.5 ml poly-
propylene tubes using stainless steel beads and a TissueLyser
(Qiagen, Hilden, Germany) for 2 min at 25 Hz. QIAZol (Qiagen) was
added to the samples andmixed for 2min at 25 Hz. Chloroformwas
added (0.2 mL/mL QIAZol) and mixed. Tubes were centrifuged at
13,000 rpm for 15 min at 4C. Total RNA was isolated using the
RNeasy mini kit (Qiagen) according to the manufacturers protocol.
DNaseI was used to remove contaminating genomic DNA from the
isolated RNA (Qiagen).
Quantitative PCR (qPCR)
All software and reagents for the analyses were purchased from
Applied Biosystems (Carlsbad, CA, USA). Complementary deoxy-
ribonucleic acid (cDNA)wasprepared from200ng totalRNAusing the
HighCapacitycDNAReverseTranscriptionKit. qPCRwasperformed in
duplicates with cDNA corresponding to 2.5 ng RNA and TaqMan
Universal master mixture with 1 assay-on-demand mixes of
primers for the genes (assay numbers in brackets): ACAN
(Hs00153936_ml), SOX9 (Hs00165814_m1), COL10A1 (Hs001
66657_m1), COL2A1 (Hs_00156568), GDF5 (Hs00167060_m1),
MMP13 (Hs00233992_m1), ADAMTS4 (Hs00192708_m1), TIMP1
(Hs99999139_m1), TIMP3 (Hs00165949_m1), DKK1 (Hs0018
3740_m1), FRZB (Hs00173503_m1), PPARD (Hs00602622_m1), FOSL1Table II
Effects on gene expression of ECM catabolic enzymes in human articular chondrocytes af
increased GDF5 concentration. For their inhibitors, TIMP1 expression was unaffected an
replicates). Results analyzed with ANOVA, table showing mean  95% CI
Patient 1 Patient 2 Patient 3
MMP13
No GF 1.00  0.71 1.00  0.00 1.00  0.0
GDF5 10 ng/ml 0.55  0.31 0.91  0.11 0.58  0.1
GDF5 100 ng/ml 0.18  0.07 0.17  0.00 0.02  0.0
GDF5 200 ng/ml 0.01  0.00 0.01  0.00 0.00  0.0
ADAMTS4
No GF 1.00  0.21 1.00  0.23 1.00  0.2
GDF5 10 ng/ml 0.99  0.63 0.94  0.12 0.48  0.1
GDF5 100 ng/ml 0.75  0.14 0.65  0.03 0.32  0.1
GDF5 200 ng/ml 0.79  0.12 0.50  0.02 0.25  0.1
TIMP1
No GF 1.00  0.09 1.00  0.14 1.00  0.0
GDF5 10 ng/ml 0.95  0.16 1.02  0.12 0.98  0.0
GDF5 100 ng/ml 0.70  0.18 0.59  0.12 0.82  0.2
GDF5 200 ng/ml 0.36  0.08 0.60  0.08 0.70  0.0
TIMP3
No GF 1.00  0.42 1.00  0.73 1.00  0.0
GDF5 10 ng/ml 1.49  0.64 0.98  0.22 1.88  0.2
GDF5 100 ng/ml 1.68  0.53 4.20  0.44 4.65  1.3
GDF5 200 ng/ml 2.78  0.55 5.21  1.91 3.50  0.3(Hs04187685_m1), with PPIA (Hs99999904_m1) as reference gene.
PCRwas performed using the 7900HT fast real-time PCR system (Life
Technologies). Relative quantiﬁcation of the target gene expression
was performed according to the standard curvemethod calculated by
the ddCqmethodwith detection limit at 37 cycles for all genes except
COL10A1 where detection limit was set to 40 to allow for statistical
analysis.
Size assessment of pellets
Pellets in the 96-well plates were investigated under the DIA-
PHOT300microscope (Nikon, Corp., Tokyo, Japan) and photographed
with a DXM1200 camera (Nikon). The size of the pellet was deter-
mined with the ImageJ software (National Institutes of Health, USA).
Biochemical analysis of pellets
On day 21 the pellets were digested with papain (Sigma) solution
as previously described31, mechanically dissolved by vortex and
analyzed for DNA and glycosaminoglycan (GAG) content. Quantiﬁ-
cation of DNA was performed with a Hoechst 33258 (Sigma) assay,
according to the manufacturers instructions. DNA values were
normalized against unstimulated control for statistical analysis.
Starting amounts of DNA at day 0 of pellet culturewere estimated for
250,000 cells in each pellet. Per pellet, 250,000 cells gives
250,000 * 7.7 pg DNA/cell32 ¼ 1.9 mg DNA per pellet. GAG was quan-
tiﬁedwith adimethylmethyleneblueassayaspreviously described33.
Histology of pellets
On day 21 the pellets were ﬁxed in Histoﬁx (Histolab Products
AB, Gothenburg, Sweden), dehydrated and embedded in parafﬁn.ter GDF5 stimulation. ForMMP13 and ADAMTS4 gene expression were reduced with
d TIMP3 expression was increased in a GDF5 dose dependent manner (n ¼ 5, three
Patient 4 Patient 5 P-value
2 1.00  0.54 1.00  0.23
4 0.24  0.11 0.94  0.30 0.93
1 0.01  0.00 0.50  0.00 0.047
0 0.01  0.00 0.12  0.01 0.00038
6 1.00  0.25 1.00  0.35
7 0.82  0.43 1.05  0.33 0.73
3 0.72  0.05 0.61  0.13 0.037
7 0.66  0.24 0.66  0.12 0.018
3 1.00  0.07 1.00  0.06
6 0.68  0.06 1.06  0.20 0.99
8 0.66  0.12 0.75  0.13 0.91
9 0.63  0.20 0.66  0.07 0.83
4 1.00  0.05 1.00  0.18
9 1.21  0.18 1.29  0.33 0.23
1 1.78  0.33 2.82  0.15 <0.0001
2 1.88  0.98 2.83  0.30 0.00014
Fig. 1. Expression of active MMP13 protein was reduced by the chondrocytes when
stimulated with 200 ng/ml GDF5 (n ¼ 3, three pooled replicates). Results analyzed
with ANOVA.
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and placed onto Super frost plus microscope slides (Menzel-Gläser,
Braunschweig, Germany), deparafﬁnized and stained with Alcian
Blue van Gieson staining. Slides were examined under the micro-
scope (Nikon Eclipse 90i, Nikon). Pictures were taken with a Nikon
DXM1200F digital camera (Nikon) and the NIS Elements D software
(Nikon).DKK1, b-catenin and active MMP13 ELISAs
On day 18, 200 ml of fresh medium was added to the pellet
cultures. On day 21 medium was collected and stored at 20C
until analysis. Medium (100 ml) from each culture was analyzed
with the human DKK1 ELISA (R&D Systems) according to the
manufacturers protocol. For the active MMP13 ELISA media from
three pellets were pooled to a volume of 600 ml and concentrated
to 250 ml with Amicon Ultra-4 Centrifugal Filter Unit, cut-off 3 kDaTable III
GDF5 stimulation shifted the chondrocytes into an anabolic state. Gene expression of ACAN
detected at the highest concentrations of GDF5 stimulation (n ¼ 5, three replicates). R
UD ¼ Undetectable
Patient 1 Patient 2 Patient 3
MMP13
No GF 1.00  0.03 1.00  0.33 1.00  0.0
GDF5 10 ng/ml 1.03  0.26 1.52  0.31 4.54  0.2
GDF5 100 ng/ml 3.57  1.10 8.57  2.21 5.72  1.0
GDF5 200 ng/ml 13.07  3.07 11.01  1.31 5.13  0.8
SOX9
No GF 1.00  0.05 1.00  0.28 1.00  0.0
GDF5 10 ng/ml 1.11  0.22 1.01  0.51 1.03  0.0
GDF5 100 ng/ml 1.51  0.33 1.56  0.42 1.12  0.1
GDF5 200 ng/ml 2.21  0.22 1.57  0.47 1.45  0.5
COL10
No GF 1.00  0.06 1.00  0.06 1.00  0.0
GDF5 10 ng/ml 0.81  0.12 0.75  0.23 1.05  0.1
GDF5 100 ng/ml 0.50  0.09 0.46  0.11 0.27  0.0
GDF5 200 ng/ml 0.43  0.14 0.31  0.15 0.25  0.0
GDF5
No GF 1.00  0.18 1.00  0.05 1.00  0.1
GDF5 10 ng/ml 1.09  0.28 0.93  0.12 0.95  0.0
GDF5 100 ng/ml 0.86  0.06 0.26  0.01 0.39  0.0
GDF5 200 ng/ml 0.44  0.10 0.26  0.09 0.30  0.0according to the manufacturers protocol (Millipore). Media
(200 ml) from each sample were then analyzed with the active
MMP13 ELISA (R&D Systems) according to the manufacturers
protocol. For the total b-catenin, three pellets were pooled in
1.5 ml polypropylene tubes and stored at 80C. ELISA kit lysis
buffer (100 ml) was added to each tube with a 5 mm stainless steel
bead (Qiagen). Samples were homogenized in a TissueLyser (Qia-
gen), 2  2 min, 25 Hz, and diluted with 50 ml of the ELISA kit lysis
buffer and stored at 80C until analysis. Total protein content
was determined with a bicinchoninic acid protein quantiﬁcation
kit (Sigma). A human total b-catenin ELISA kit (R&D Systems) was
used to analyze 100 ml of each sample, according to the manu-
facturers instructions. Protein concentrations in the samples were
determined with a BCA protein assay kit (Thermo Scientiﬁc,
Rockford, IL, USA).Ethical approval
Cartilage donations were approved by the ethical committee at
The Sahlgrenska Academy, University of Gothenburg.Statistics
The separate experiments in this study included 1e6 patients
(n) per group as stated in ﬁgure texts, with three replicates per n
unless otherwise stated. For qPCR analysis, data were normalized
to non-stimulated control group. Results are displayed as mean for
each patient 95% conﬁdence interval (CI) determined from three
replicates. Differences between stimulations were analyzed by
Student’s t test or one-way analysis of variance (ANOVA) with the
Tukey post hoc test and P-values considered signiﬁcant at P < 0.05.
To take intra-patient variability into account each replicate was
used as a separate value. SPSS (IBM Corporation, Armonk, NY, USA)
and GraphPad Prism software (GraphPad Software Inc., La Jolla,
CA, USA) were used for statistical analyses. For the factorial DoE,
multiple linear regression (MLR) using least square methodologyand SOX9were increased upon GDF5 stimulation. Reduced expression of COL10was
esults analyzed with ANOVA, table showing mean  95% CI. GF ¼ Growth factor.
Patient 4 Patient 5 P-value
2 1.00  0.07 1.00  0.08
9 0.77  0.21 4.07  0.76 0.95
5 2.42  0.34 16.36  0.37 0.045
8 5.11  0.78 20.51  1.14 0.00059
3 1.00  0.09 1.00  0.11
6 1.00  0.11 0.97  0.11 0.99
6 1.77  0.73 1.00  0.09 0.11
6 1.81  0.43 1.25  0.11 0.0034
5 1.00  0.05 1.00  0.06
2 0.37  0.14 1.25  0.10 0.99
5 UD  UD  0.014
0 UD  UD  0.0060
3 1.00  0.02 1.00  0.06
6 0.89  0.07 0.82  0.05 0.99
6 0.43  0.03 0.34  0.03 0.0070
6 0.44  0.16 0.24  0.04 <0.0001
L. Enochson et al. / Osteoarthritis and Cartilage 22 (2014) 566e577570was used for the analysis in Modde 8.0 and models considered
signiﬁcant at P < 0.05 and without a signiﬁcant lack of ﬁt at
P > 0.05.
Results
GDF5 stimulation reduces expression of matrix degrading enzymes
Stimulating human chondrocyte pellets with GDF5 resulted in
dose dependent decreases in gene expressions of the matrix
degrading enzymes MMP13 and ADAMTS4, with the strongest
reduction at the highest GDF5 concentration, 200 ng/ml, for both
MMP13 (33-fold, P ¼ 0.00038) and ADAMTS4 (1.75-fold,
P ¼ 0.018), compared with control. TIMP1 gene expression was
unaffected by the GDF5 stimulation (P ¼ 0.67) and TIMP3 expres-
sion was increased (þ3.2-fold, P ¼ 0.00014) (Table II). The reduced
gene expression levels of MMP13 were reﬂected by reduced
amounts of active MMP13 protein in the culture medium of pellets
stimulated with 200 ng/ml GDF5 (1.3-fold, P ¼ 0.032) [Fig. 1],
compared with control.
GDF5 stimulation shift human chondrocytes into an anabolic state
Expression of genes associated with chondrocyte differentiation
and ECM production increased in a dose dependent manner in
response to GDF5 stimulation, ACAN (þ11-fold, P ¼ 0.00060) and
SOX9 (þ3.5-fold, P ¼ 0.0012). GDF5 stimulation also reduced hy-
pertrophic differentiation of the cells as COL10 expression was
downregulated at 100 ng/ml and 200 ng/ml GDF5 stimulation. The
endogenous expression of GDF5 was decreased as a result of the
stimulations (3.0-fold, P < 0.0001) (Table III). After 21 days in
culture there were signiﬁcant dose dependent increases in total
DNA content in pellets stimulated with GDF5 (þ3.1-fold,
P ¼ 0.00063), compared with control. The GAG/DNA ratio, that
reﬂects the matrix producing capacity of the cells, increased with
GDF5 stimulation in a dose dependent manner (þ4.3-fold,
P¼ 0.0015), comparedwith control. Pellet size increasedwith GDF5
Table IV
Pellet size increased with increased GDF5 stimulation. The largest increase was seen at
increased total amounts of DNA with increased GDF5 concentration. Amount of DNA p
increased with increasing GDF5 concentration. Results analyzed with ANOVA, table show
Patient 1 Patient 2 Patient 3
DNA
No GF 2012  119 333  26 710  16
GDF5 10 ng/ml 3087  958 401  13 4555  38
GDF5 100 ng/ml 3526  558 604  104 5397  57
GDF5 200 ng/ml 2957  929 871  273 6227  59
GAG/DNA
No GF 1.00  0.00 1.00  0.00 0.87  0.4
GDF5 10 ng/ml 1.09  0.81 0.91  0.42 2.42  0.3
GDF5 100 ng/ml 3.26  1.54 3.96  0.26 3.07  0.0
GDF5 200 ng/ml 2.83  1.51 5.20  0.39 3.60  0.1
Pellet size
No GF 1.00  0.09 1.00  0.04 0.99  0.3
GDF5 10 ng/ml 0.99  0.09 0.95  0.12 1.41  0.3
GDF5 100 ng/ml 1.44  0.10 1.16  0.09 1.79  0.7
GDF5 200 ng/ml 2.93  0.12 1.23  0.11 2.34  0.2stimulation (þ2.5-fold, P < 0.0001) compared with control
(Table IV). Histology sections stained with Alcian Blue van Gieson
conﬁrmed the increase in proteoglycan rich ECM after GDF5 stim-
ulation, as compared with control [Fig. 2].
Biological relevance of the in vitro system
To assess the biological relevance of the in vitro system used
herein, expression levels of GDF5, SOX9, ACAN, COL2A1, andMMP13
were compared to those in normal and OA cartilage biopsies
[Fig. 3]. ACAN and COL2A1 expressions were higher in the biopsies,
SOX9 andMMP13 expressions were similar in the two systems, and
GDF5 expression was higher in the in vitro system.
GDF5 stimulation inhibits canonical Wnt signaling in human
chondrocytes
GDF5 stimulation resulted in increased mRNA expressions of
two inhibitors of canonical Wnt signaling, DKK1 (þ12-fold,
P ¼ 0.00032) and FRZB (þ5.1-fold, P ¼ 0.017) (Table V). An increase
in DKK1 protein levels was measured in the medium of pellets
cultured in the presence of 200 ng/ml GDF5 as compared with
control (þ4.0-fold, P < 0.0001) [Fig. 4(A)]. Protein quantiﬁcation of
b-catenin revealed reductions in total b-catenin in the GDF5 stim-
ulated cells (1.3-fold, P ¼ 0.00022), indicating an inhibition of the
canonical Wnt signaling pathway [Fig. 4(B)]. Inhibition of the
signaling pathway was conﬁrmed with qPCR, showing down-
regulation of the canonical Wnt pathway downstream genes FOSL1
(1.36-fold, P ¼ 0.016) and PPARD (1.33-fold, P ¼ 0.040)
[Fig. 4(C)e(D)].
GDF5 stimulation reduces Wnt signaling induced MMP13 expression
In order to investigate and validate the role of canonical Wnt
signaling for the expression of matrix modulating genes in our
culture system we activated the canonical Wnt pathway. Stimula-
tion with the small molecule GSK3b inhibitor CHIR-99021the highest GDF5 concentration (n ¼ 3). Biochemical analysis of the pellets showed
er pellet at day 0 was 1.9 mg (n ¼ 5, three replicates). The GAG/DNA ratio was also
ing mean  95% CI
Patient 4 Patient 5 P-value
3 3234  390 1599  763
4 4994  860 3939  363
5121  2057 5605  255 0.014
2 7979  2146 6296  390 0.00062
0 0.88  0.26 1.01  0.32
2 1.63  0.51 0.83  0.35
7 2.99  0.48 3.30  0.27 0.077
1 3.45  0.53 2.53  0.10 0.015
2
5
0 0.0023
5 0.00027
Fig. 2. Representative images of the histological pellet sections. Alcian Blue van Gieson staining showing increased proteoglycan expression with increased GDF5 concentration
from 0 ng/ml (left) to 200 ng/ml (right), scale bar 200 mm (n ¼ 5).
Fig. 3. Relative gene expression levels in non-stimulated pellets (n ¼ 3, mean from three replicates each) and pellets (n ¼ 3, mean from three replicates each) stimulated with
200 ng/ml GDF5 compared with expression levels in normal (N) (n ¼ 6, no replicates) and OA (n ¼ 5, no replicates) cartilage biopsies of selected markers A) GDF5, B) SOX9, C) ACAN,
D) COL2A1 and E) MMP13. Results analyzed with ANOVA, horizontal lines show mean.
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Table V
GDF5 stimulation induced expression of Wnt inhibitors. Gene expressions of A) DKK1 and B) FRZB increased in a dose dependent manner (n ¼ 5, 3 replicates)
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 P-value
DKK1
No GF 1.00  0.00 1.00  0.00 1.00  0.00 1.00  0.15 1.00  0.00
GDF5 10 ng/ml 0.27  0.00 1.00  0.00 2.46  0.14 2.30  1.60 4.13  1.42 0.99
GDF5 100 ng/ml 0.69  0.23 1.19  1.27 18.38  8.29 9.21  0.87 4.35  1.73 0.012
GDF5 200 ng/ml 3.34  0.16 6.58  0.06 24.47  9.28 15.34  6.20 10.02  1.17 0.0024
FRZB
No GF 1.00  0.12 1.00  0.28 1.00  0.03 1.00  0.55 1.00  0.13
GDF5 10 ng/ml 1.20  0.13 1.22  0.66 1.93  0.25 0.83  0.12 1.94  0.58 0.85
GDF5 100 ng/ml 3.62  1.76 5.50  2.49 2.72  0.09 1.95  0.29 4.57  0.18 0.11
GDF5 200 ng/ml 6.22  2.14 7.04  3.07 3.43  0.89 3.35  1.02 4.96  3.29 0.018
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anabolic genes in the chondrocyte pellets, compared with control:
MMP13 (þ5.1-fold, P¼ 0.023), ADAMTS (P¼ 0.67), TIMP1 (P ¼ 0.09),
TIMP3 (2.0-fold, P < 0.00001), ACAN (3.2-fold, P < 0.00001),
SOX9 (0.51-fold, P ¼ 0.00094) [Fig. 5(A)e(F)]. The active MMP13
ELISA showed that canonical Wnt pathway activation increases the
MMP13 protein levels (þ1.5-fold, P ¼ 0.047), compared with con-
trol [Fig. 5(G)]. We further investigated if Wnt ligand activation
could mediate the same matrix degrading effect. The chondrocytes
were stimulated with recombinant Wnt3a ligand, which increased
MMP13 expression in the chondrocyte cultures (þ1.87-fold,Fig. 4. Stimulating the pellets with 200 ng/ml GDF5 resulted in increased protein expressio
inhibited canonical Wnt signaling pathway. Reduced gene expressions of canonical Wnt do
pathway (n ¼ 3). Results analyzed with ANOVA, horizontal lines show mean.P < 0.0001). This increase was counteracted by GDF5 stimulation
(P < 0.0001) [Fig. 6].
Inhibition of DKK1 restores GDF5 suppressed MMP13 expression
Finally we investigated if the decreased MMP13 expression in
GDF5 stimulated chondrocyte pellets could be restored by blocking
the DKK1 protein. Adding the DKK1 inhibitor WAY-262611 at 1 mM
to chondrocyte pellet cultures stimulated with 200 ng/ml GDF5
fully restored the GDF5 suppressed MMP13 gene expression
[Fig. 7(A)]. The two-dimensional factorial design showed decreasedn of A) DKK1 and reduced amounts of B) total b-catenin protein in the cells, indicating
wnstream genes C) FOSL1 and D) PPARD conﬁrmed the inhibition of the canonical Wnt
Fig. 5. Activating the canonical Wnt pathway by blocking GSK3b with the small molecule CHIR-99021 resulted in increased matrix degradation patterns in the cells with increased
A) MMP13 and B) ADAMTS4 expressions, with unaffected C) TIMP1 expression and decreased D) TIMP3, E) ACAN and F) SOX9 expressions. Results analyzed with ANOVA, horizontal
lines show mean (n ¼ 3, three replicates). G) CHIR-99021 stimulation indicated increased active MMP13 protein expression in the cells (n ¼ 3, three pooled replicates).
L. Enochson et al. / Osteoarthritis and Cartilage 22 (2014) 566e577 573MMP13 gene expression and increased ACAN gene expression with
increased concentration of GDF5. Simultaneous stimulations with
the DKK1 inhibitor counteracted these effects in a dose dependent
manner, pmodelMMP13 ¼ 0.001, pmodelACAN ¼ 0.002 [Fig. 7(B) and (C)].Discussion
As there is a lack of knowledge regarding the function of GDF5 in
cartilage regeneration and disease, we investigated the effects of
Fig. 6. Activating the canonical Wnt pathway with 50 ng/ml recombinant Wnt3a
resulted in increased MMP13 gene expression by the cells. This expression was
counteracted by 200 ng/ml GDF5 stimulation (n ¼ 3, three replicates). Results analyzed
with ANOVA, horizontal lines show mean.
L. Enochson et al. / Osteoarthritis and Cartilage 22 (2014) 566e577574GDF5 stimulation in the pellet mass system, a frequently used
in vitro system for studying chondrogenesis. We show that GDF5
stimulation has an inhibitory effect on the expression of catabolic
genes, and a simultaneous stimulatory effect on the expression of
anabolic genes in human articular chondrocytes. GDF5 stimulation
increased the expressions of canonical Wnt inhibitors DKK1 and
FRZB, and the canonical Wnt signaling was simultaneously inhibi-
ted. Finally, we show that this inhibition is DKK1-dependent and
that the inhibition of the canonical Wnt pathway mediates theFig. 7. A) Blocking DKK1 with the DKK1 inhibitor small molecule WAY-262611 restored the
ANOVA, horizontal lines show mean. The response surfaces supported the linear results, wit
by the DKK1 inhibitor. C) Analyzing the ACAN gene expression in the same system showed th
two replicates), data analyzed with MLR using least square methodology in computer softwdownregulation of MMP13 expression. Previous studies have
shown that GDF5 has anabolic effects on chondrocytes28,29,34 which
was partly conﬁrmed in the present study. However, GDF5 stimu-
lation does not induce the same expressional levels in vitro of ACAN
and COL2A1 as the expression of these genes in vivo. Thus it could
be argued that GDF5 does not have a strong anabolic effect when it
comes to the expression of these genes in our model system. The
increased levels of DNA after GDF5 stimulation compared to the
start amount suggest a probable increased proliferation, conﬁrming
the results from Appel et al.28, or possibly a combination of prolif-
eration and reduced apoptosis. It should be noted that as the cells in
the control pellets do not express ACAN or COL2A1 to a high degree,
these cells are reasonably dedifferentiated. This can be considered a
major limitation to the study and the role for GDF5 in fully differ-
entiated chondrocyte in vivo remains to be determined. However,
the results have bearing on the regenerative and repair processes in
cartilage in that the present study clearly shows a previously un-
known biological mechanism, i.e., the connection between GDF5
stimulation and MMP13 expression through inhibition of Wnt
signaling. The MMP13 expression level in the analyzed cartilage is
similar to the levels in the pellet system, which may suggest that
the matrix protective effect of GDF5 stimulation could have phys-
iological effects although the physiological relevance in vivo needs
to be elucidated in future studies. Since the expression levels of
SOX9 and MMP13 are similar in pellet cultures and biopsies we
believe that the current model is appropriate to address the aim of
the study.
GDF5 has previously been implemented in the OA disease in
several publications. In the SNP analyses linking GDF5 to the
development of OA, the SNP results in reduced promoter activity ofGDF5 reduced MMP13 gene expression (n ¼ 2, three replicates). Results analyzed with
h B) decreasedMMP13 gene expression with increased GDF5, and a counteracting effect
e opposite effects. Relative gene expression shown in white boxes in the graphs (n ¼ 1,
are Modde 8.0. pmodelMMP13 ¼ 0.001, pmodelACAN ¼ 0.002.
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that the amounts of active MMP13 protein decreased after GDF5
stimulation and a simultaneous decrease in both MMP13 and
ADAMTS4 mRNA levels. Hypothetically this effect could have been
due to a decreased MMP13 release or increased breakdown of the
protein but this is unlikely as we show a simultaneous effect on
both mRNA and protein level. With the simultaneous increased, or
unaffected, expression levels of their inhibitors (TIMP3 and TIMP1),
matrix degradation was likely reduced, suggesting that the pres-
ence of GDF5 could counteract degenerative processes in cartilage
tissues. As the effect of GDF5 treatment was prominent in vitro
although the cells had endogenous levels of GDF5 the effect may
have physiological relevance in vivo since the expression was
comparably low in cartilage biopsies. This needs to be elucidated in
future animal studies. Our results suggest that reduced expressions
of GDF5 caused by the rs143383 T/C SNP, could have impaired
regulation of matrix degrading enzymes as a result, and even small
stimulatory reductions may be important over time27.
Our study shows that GDF5 not only affects expression of genes
linked to cartilage ECM homeostasis, but also induces expression of
Wnt inhibitor proteins DKK1 and FRZB in the chondrocytes. Both
DKK1 and FRZB are implemented in the progression of OA. Loughlin
et al.15 showed that a SNP in the FRZB gene, resulting in diminished
ability todisruptWnt signaling, increased susceptibility tohipOA. The
DKK1 protein blocks canonical Wnt signaling and its role for the
progressionofOA is debated.Honsawek et al.17 have shownthat levels
of DKK1 in plasma inversely correlates with severity of OA in human
knees and Oh et al.35 demonstrated that DKK1 inhibitsWntmediated
degradation of cartilage inmice. This is in agreement with the results
from the present study, as blocking DKK1 with the inhibitor WAY-
262611 abolished the GDF5 induced reductions in MMP13 expres-
sion. The inhibitor also increased MMP13 expression and decreased
ACAN expression at the low, ultimately ineffective, doses of GDF5 as
seen in the dose response surfaces in Fig. 7(B) and (C), likely
depending on the blocking of the endogenous DKK1 expression.
In contrast it should be noted thatWeng et al.20,21 have shown in
two studies that DKK1 stimulation induces chondrocyte apoptosis
and cartilage destruction. This two faced role of DKK1 shows that
its expression needs to be carefully controlled in the cartilage
tissue.
In this study, following the increase of the inhibitors, the GDF5
stimulation led to reductions in b-catenin amounts in the cells and
downregulation of downstream genes of the canonical Wnt
pathway, indicating inhibition of the pathway. Similar to the role of
DKK1, the canonical Wnt pathway is also two faced. Zhu et al.36
described increased chondrocyte apoptosis after b-catenin inhibi-
tion and Yasuhara et al.37 showed that Wnt signaling activation in
mouse articular cartilage superﬁcial zone cells stimulated prolif-
eration and maintained a phenotypic expression of proteoglycan 4
and transcriptional regulator v-ets avian erythroblastosis virus E26
oncogene homolog (ERG) in vitro. Several studies show the negative
effects of active canonicalWnt signaling for cartilage formation and
homeostasis with increased apoptosis and growth retardation in
growth plate chondrocytes6e8,38. Miclea et al.7 inhibited chondro-
genesis by blocking GSK3b with the small molecule CHIR-99021,
revealing that active canonical Wnt signaling increases cell death
and MMP13 expression in chondrocytes, and that the resulting
cartilage tissue is phenotypically similar to that of OA tissue. Active
canonical Wnt signaling has also been shown to prevent early
chondrogenesis and during endochondral bone formation it in-
duces the maturation of hypertrophic chondrocytes with the
expression of collagen X and MMP13, and it promotes bone for-
mation5,6,8. Due to the contradictory reports of canonical Wnt
signaling in relation to cartilage tissue homeostasis we investigated
the effects of an active canonical Wnt signal in humanchondrocytes in our culture system. Stimulation with the GSK3b
inhibitor CHIR-99021 revealed increased matrix degradation.
Activation of the pathway in the cells with recombinant Wnt3a
similarly increased expression of MMP13. Interestingly, the effects
of Wnt3a were counteracted by GDF5 stimulation. As shown in the
present study this effect is likely mediated by DKK1 expression.
Investigating which concentration levels of Wnt3a that GDF5 can
counteract needs to be further elucidated in future studies in order
to assess the physiological relevance.
Some members of the bone morphogenetic family, such as
BMP2 and BMP4, are powerful inducers of bone formation in
mesenchymal stem cells and in a study by Papathanasiou et al.39,
BMP2 was shown to activate the canonical Wnt pathway in human
chondrocytes. This activation resulted in upregulation of COL10
expression and induced hypertrophy. In comparison, no such ef-
fects were seen with the GDF5 stimulation in this study, as COL10
expression was reduced by GDF5 stimulation.
In contrast to our results, underlining the dual role of the ca-
nonical Wnt signaling pathway, Ma et al.40 showed in a short-term
study that active canonical Wnt signaling in cartilage explants has
inhibiting effects on MMP13 expression on gene expression level.
The differences to our study could be that our stimulation
continued for a longer period of time and that our cells were
retrieved from younger patients. Furthermore, in a study by Del-
l’Accio et al.11, acute trauma was shown to increase levels of Wnt
and Wnt associated proteins. The trauma also induced MMP13
expression in human cartilage explants. An activation of the ca-
nonical Wnt pathway did, however, appear to be linked to a short-
term upregulation of COL2A1 and ACAN, indicating anabolic effects.
The differences in results could stem from the different stimulatory
time scales investigated, the difference in donor material and/or
the differences in the way the pathway was stimulated.
Control of Wnt signaling is thus essential, as both up and
downregulation of the pathway can affect cartilage negatively. Over
longer time courses, canonical Wnt signaling seems to be harmful
for cartilage tissue homeostasis.
In conclusion, the present study shows that GDF5 appears to
have a role in the inhibition of canonical Wnt signaling and that it
has effects on degenerative processes. The results may contribute to
the knowledge about the molecular mechanisms responsible for
the etiology of OA and could to some extent contribute to the un-
derstanding of the close link between the SNP in the GDF5 gene and
the increased susceptibility to develop OA.
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